APM Stock Summary and Trading Ideas (Aptorum Group Limited - Class A | NASDAQ:APM)

Aptorum Group Ltd clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. The company operates in two segments: Therapeutics and Non-Therapeutics. The projects are ALS-4, SACT-1, and RPIDD. It is also engaged in providing healthcare services.

Aptorum Group Limited - Class A trades on the NASDAQ stock market under the symbol APM.

As of March 6, 2025, APM stock price climbed to $0.99 with 27,216 million shares trading.

APM has a beta of 1.78, meaning it tends to be more sensitive to market movements. APM has a correlation of 0.01 to the broad based SPY ETF.

APM has a market cap of $7.07 million. This is considered a Sub-Micro Cap stock.

In the last 3 years, APM traded as high as $17.80 and as low as $.46.

The top ETF exchange traded funds that APM belongs to (by Net Assets): ONEQ.

APM has underperformed the market in the last year with a price return of -31.7% while the SPY ETF gained +14.3%. However, in the short term, APM had mixed performance relative to the market. It has outperformed in the last 3 months, returning +32.8% vs -5.3% return in SPY. But in the last 2 weeks, APM shares have been beat by the market, returning -13.9% compared to an SPY return of -6.6%.

APM support price is $.89 and resistance is $1.07 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that APM shares will trade within this expected range on the day.